328 related articles for article (PubMed ID: 34678719)
1. Dietary natural products as a potential inhibitor towards advanced glycation end products and hyperglycemic complications: A phytotherapy approaches.
M V; Wang K
Biomed Pharmacother; 2021 Dec; 144():112336. PubMed ID: 34678719
[TBL] [Abstract][Full Text] [Related]
2. A review on mechanism of inhibition of advanced glycation end products formation by plant derived polyphenolic compounds.
Anwar S; Khan S; Almatroudi A; Khan AA; Alsahli MA; Almatroodi SA; Rahmani AH
Mol Biol Rep; 2021 Jan; 48(1):787-805. PubMed ID: 33389535
[TBL] [Abstract][Full Text] [Related]
3. Phytochemicals against anti-diabetic complications: targeting the advanced glycation end product signaling pathway.
Parveen A; Sultana R; Lee SM; Kim TH; Kim SY
Arch Pharm Res; 2021 Apr; 44(4):378-401. PubMed ID: 33837513
[TBL] [Abstract][Full Text] [Related]
4. Advanced Glycation End Products and Diabetes Mellitus: Mechanisms and Perspectives.
Khalid M; Petroianu G; Adem A
Biomolecules; 2022 Apr; 12(4):. PubMed ID: 35454131
[TBL] [Abstract][Full Text] [Related]
5. Phytochemicals as Potential Inhibitors of Advanced Glycation End Products: Health Aspects and Patent Survey.
Fernandes ACF; Melo JB; Genova VM; Santana ÁL; Macedo G
Recent Adv Food Nutr Agric; 2022 Nov; 13(1):3-16. PubMed ID: 34053432
[TBL] [Abstract][Full Text] [Related]
6. Therapeutic options to reduce advanced glycation end products in patients with diabetes mellitus: A review.
Jud P; Sourij H
Diabetes Res Clin Pract; 2019 Feb; 148():54-63. PubMed ID: 30500546
[TBL] [Abstract][Full Text] [Related]
7. Advanced glycation end products in diabetes, cancer and phytochemical therapy.
Dariya B; Nagaraju GP
Drug Discov Today; 2020 Sep; 25(9):1614-1623. PubMed ID: 32652310
[TBL] [Abstract][Full Text] [Related]
8. The Development of Maillard Reaction, and Advanced Glycation End Product (AGE)-Receptor for AGE (RAGE) Signaling Inhibitors as Novel Therapeutic Strategies for Patients with AGE-Related Diseases.
Shen CY; Lu CH; Wu CH; Li KJ; Kuo YM; Hsieh SC; Yu CL
Molecules; 2020 Nov; 25(23):. PubMed ID: 33261212
[TBL] [Abstract][Full Text] [Related]
9. Glucopyranoside flavonoids isolated from leaves of Spinacia oleracea (spinach) inhibit the formation of advanced glycation end products (AGEs) and aldose reductase activity (RLAR).
Perez Gutierrez RM; Velazquez EG
Biomed Pharmacother; 2020 Aug; 128():110299. PubMed ID: 32521451
[TBL] [Abstract][Full Text] [Related]
10. Natural Alkaloids and Diabetes Mellitus: A Review.
Ajebli M; Khan H; Eddouks M
Endocr Metab Immune Disord Drug Targets; 2021; 21(1):111-130. PubMed ID: 32955004
[TBL] [Abstract][Full Text] [Related]
11. Advanced glycation end products and insulin resistance.
Unoki H; Yamagishi S
Curr Pharm Des; 2008; 14(10):987-9. PubMed ID: 18473850
[TBL] [Abstract][Full Text] [Related]
12. Suppression in advanced glycation adducts of human serum albumin by bio-enzymatically synthesized gold and silver nanoformulations: A potential tool to counteract hyperglycemic condition.
Ahmed F; Husain Q
Biochimie; 2019 Jul; 162():66-76. PubMed ID: 30959081
[TBL] [Abstract][Full Text] [Related]
13. Natural products as anti-glycation agents: possible therapeutic potential for diabetic complications.
Elosta A; Ghous T; Ahmed N
Curr Diabetes Rev; 2012 Mar; 8(2):92-108. PubMed ID: 22268395
[TBL] [Abstract][Full Text] [Related]
14. Prevention of advanced glycation end-products formation in diabetic rats through beta-cell modulation by Aegle marmelos.
Hafizur RM; Momin S; Fatima N
BMC Complement Altern Med; 2017 Apr; 17(1):227. PubMed ID: 28431540
[TBL] [Abstract][Full Text] [Related]
15. Phytochemicals Against Advanced Glycation End Products (AGEs) and the Receptor System.
Yamagishi SI; Matsui T; Ishibashi Y; Isami F; Abe Y; Sakaguchi T; Higashimoto Y
Curr Pharm Des; 2017; 23(8):1135-1141. PubMed ID: 27774900
[TBL] [Abstract][Full Text] [Related]
16. Role of advanced glycation end products (AGEs) and oxidative stress in diabetic retinopathy.
Yamagishi S; Ueda S; Matsui T; Nakamura K; Okuda S
Curr Pharm Des; 2008; 14(10):962-8. PubMed ID: 18473846
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products (AGEs) and their receptor (RAGE) system in diabetic retinopathy.
Yamagishi S; Nakamura K; Matsui T
Curr Drug Discov Technol; 2006 Mar; 3(1):83-8. PubMed ID: 16712466
[TBL] [Abstract][Full Text] [Related]
18. Involvement of the toxic AGEs (TAGE)-RAGE system in the pathogenesis of diabetic vascular complications: a novel therapeutic strategy.
Takeuchi M; Takino J; Yamagishi S
Curr Drug Targets; 2010 Nov; 11(11):1468-82. PubMed ID: 20583971
[TBL] [Abstract][Full Text] [Related]
19. Role of Advanced Glycation Endproduct (AGE)-Receptor for Advanced Glycation Endproduct (RAGE) Axis in Cardiovascular Disease and Its Therapeutic Intervention.
Yamagishi SI
Circ J; 2019 Aug; 83(9):1822-1828. PubMed ID: 31366777
[TBL] [Abstract][Full Text] [Related]
20. Food-derived advanced glycation end products (AGEs): a novel therapeutic target for various disorders.
Yamagishi S; Ueda S; Okuda S
Curr Pharm Des; 2007; 13(27):2832-6. PubMed ID: 17897026
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
